Yellow Card Scheme - Cancer Science

Relevant Publications

An Evaluation of Oral Anticoagulant Safety Indicators by England\'s Community Pharmacies.

Issue Release: 2024

Bridging the gap from medical to psychological safety assessment: consensus study in a digital mental health context.

Issue Release: 2024

Regulatory adverse drug reaction analyses support a temporal increase in psychiatric reactions after initiation of cystic fibrosis combination modulator therapies.

Issue Release: 2024

Assessing and further developing age-appropriate information for young people about reporting suspected adverse drug reactions.

Issue Release: 2023

Quantitative and qualitative analysis of individual experiences post botulinum toxin injection - United Kingdom Survey.

Issue Release: 2023

Under-reporting of gastrointestinal bleeding associated with anticoagulant use using the UK Yellow Card Scheme.

Issue Release: 2023

Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme.

Issue Release: 2022

Covid-19 vaccines: we need immediate release of anonymised data from yellow card scheme.

Issue Release: 2022

Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.

Issue Release: 2022

Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?

Issue Release: 2022

Information for children and young people about reporting suspected adverse drug reactions.

Issue Release: 2022

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.

Issue Release: 2022

Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.

Issue Release: 2022

Implementing a specialist paediatric clinical pharmacology service in a UK children\'s hospital.

Issue Release: 2021

Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions.

Issue Release: 2021

Close to a Decade of Decrease in Antimicrobial Usage in Danish Pig Production-Evaluating the Effect of the Yellow Card Scheme.

Issue Release: 2020

Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports.

Issue Release: 2020

Scoping review of approaches for improving antimicrobial stewardship in livestock farmers and veterinarians.

Issue Release: 2020

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.

Issue Release: 2020

Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group.

Issue Release: 2020

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Yellow Card Scheme - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics